title: Hypertension in the Hemodialysis Patient.
abstract: Hypertension is common yet difficult to manage in the hemodialysis patients population. This chapter discusses various aspects of this problem including its prevalence, distinctive pathophysiology, methods of diagnosis and pharmacological and non pharmacological treatment approaches. The topic is relevant to any health care provider taking care of hemodialysis patients.
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN, USA, 55905.
authors.forename: Musab
authors.initials: M
authors.lastname: Hommos
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN, USA, 55905. Schinstock.carrie@mayo.edu.
authors.forename: Carrie
authors.initials: C
authors.lastname: Schinstock
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination; D005440:Fluid Therapy; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D007668:Kidney / Q000503:physiopathology*; D007674:Kidney Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects; D012307:Risk Factors; D016896:Treatment Outcome; D014882:Water-Electrolyte Balance / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents
keywords: Aldosterone; Ambulatory blood pressure monitoring; Arterial stiffness; Blood pressure target; Extracellular volume; Hyperparathyroidism; Renin-angiotensin system; Sodium balance; Sympathetic nervous system